logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Geraldine R. Vink

research and development
H指数:25
被引数:3,417

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predicting health-related quality of life two years post-diagnosis across seven cancer types: using machine learning to identify vulnerable patients

预测7种癌症类型确诊后2年的健康相关生活质量：利用机器学习识别易感患者

Quality of Life Research
IF2.7
2026-02-120
OAAI
Willemijn F. Oudijk; Belle H. de Rooij; Koen J. van Benthem; Rampal S. Etienne; Simone Oerlemans; Helena M. Verkooijen; Katja K. H. Aben; Geraldine R. Vink; Anne M. May; Floortje Mols; Dimitris Katsimpokis; Nicole P. M. Ezendam
Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients

III期结肠癌患者对辅助化疗耐药的癌症相关成纤维细胞特征和SMAD4突变

European Journal of Cancer
IF7.1
2026-01-310
OAAI
Ingrid A. Franken; Steven L.C. Ketelaars; Carmen Rubio-Alarcón; Pien Delis-van Diemen; Tessa O.M. Spaapen; Floor Heilijgers; Marcos da Silva Guimaraes; Sietske C.M.W. van Nassau; Suzanna J. Schraa; Wilma E. Mesker; Wendy W.J. de Leng; Onno Kranenburg; Gerrit A. Meijer; Miriam Koopman; Mark Sausen; Geraldine R. Vink; Sanne Abeln; Remond J.A. Fijneman; Jeanine M.L. Roodhart
Added value of tumor–stroma ratio to postsurgery circulating tumor DNA and pTN stage in risk stratification of patients with stage III colon cancer treated with adjuvant chemotherapy

肿瘤-间质比率对接受辅助化疗的III期结肠癌患者风险分层中术后循环肿瘤DNA和pTN分期的附加价值

ESMO Open
IF8.3
2026-01-020
OAAI
I.A. Franken; F. Heilijgers; M.-C.E. Bakker; C. Rubio-Alarcón; F.H. van der Baan; M. Lemmens; P. Delis-van Diemen; M. Sausen; G.A. Meijer; M. Koopman; G.R. Vink; R.J.A. Fijneman; W.E. Mesker; J.M.L. Roodhart
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness

CtDNA指导下的辅助化疗降级治疗在III期结肠癌中的应用：基于模型的早期成本效益评估

Therapeutic Advances in Medical Oncology
IF4.2
2025-11-060
OA
Haoyue Wang; Astrid Kramer; Marjolein J. E. Greuter; Carmen Rubio-Alarcón; Birgit Lissenberg-Witte; Gerrit A. Meijer; Niels F. M. Kok; Daan van den Broek; Geraldine R. Vink; Jeanine M. L. Roodhart; Mark Sausen; Remond J. A. Fijneman; Veerle M. H. Coupé
Recommendations and definitions for time-to-event endpoints using real-world data in oncology

基于真实世界数据的肿瘤学中时间-事件终点的建议与定义

ESMO Real World Data and Digital Oncology
IF0
2025-11-010
OA
Vissers, P. A. J.; Elferink, M. A. G.; Bijlsma, M. J.; van der Geest, L. G.; Koopman, M.; van Laarhoven, H. W. M.; Nieuwenhuijzen, G. A. P.; van Rossum, P. S. N.; Sijtsma, F. P. C.; Vink, G. R.; de Vos-Geelen, J.; Wilmink, H. W.; de Wilt, J. H. W.; Verhoeven, R. H. A.; van Erning, F. N.
A comparison by mismatch repair status of real-world characteristics and outcomes in patients with stage II/III rectal cancer in the Netherlands

基于错配修复状态的荷兰期II/III直肠癌症患者真实世界特征与结局的比较

International Journal of Cancer
IF4.7
2025-09-080
OAAI
Renee A. Lunenberg; Ingrid A. Franken; Frederieke H. van der Baan; Femke P. C. Sijtsma; Geraldine R. Vink; Manon N. G. J. A. Braat; Leon M. G. Moons; Miangela M. Lacle; Marloes A. G. Elferink; Susan Boklage; Martijn P. W. Intven; Jamie Garside; Miriam Koopman; Rob van Wuijtswinkel; Jeanine M. L. Roodhart
DuTOC: The prospective Dutch Thoracic Oncology Cohort: A nationwide infrastructure to collect clinical data, PROMS and bio-material to support thoracic oncology studies

DuTOC：荷兰胸癌前瞻性队列研究：一个全国性的基础设施，用于收集临床数据、患者报告结局测量（PROMs）和生物材料，以支持胸癌研究

Lung Cancer
IF4.4
2025-08-260
OAAI
W.K. de Jong; F.T.A. van der Velde; A. Keijser; H.J.M. Groen; A.S.R. van Lindert; G.R. Vink; L.E.L. Hendriks; M.M. van den Heuvel
Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative

促进欧洲胃肠道癌症大型跨国学术临床研究：ENGIC（欧洲胃肠道癌症网络）倡议

ESMO OPEN
IF8.3
2025-05-010
OA
Taieb, J.; Seligmann, J.; Modest, D.; Girault, C.; Rivera, F.; Mahillo, E.; Osterlund, P.; Pfeiffer, P.; Malka, D.; Louvet, C.; Siebenhuner, A. R.; Morf, C.; de la Fouchardiere, C.; Monard, L.; Koopman, M.; Vink, G.; Borbath, I.; Dewever, L.; Adams, R.; Reinacher-Schick, A.; Pietrantonio, F.; Lonardi, S.; Aparicio, T.; Cremolini, C.
Mismatch repair deficient, stage II/III rectal cancer: Real-world patient, tumour, and treatment characteristics in the Netherlands

错配修复缺陷型，II/III期直肠癌：荷兰真实世界患者、肿瘤和治疗特征

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Lunenberg, R. A.; Franken, I. A.; van der Baan, F. H.; Sijtsma, F. P. C.; Vink, G.; Koopman, M.; Intven, M.; Braat, M. N. G. J. A.; Moons, L.; Lacle, M.; Elferink, M.; Boklage, S. H.; Garside, J.; Wuijtswinkel, R. V.; Roodhart, J. M. L.
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer

ctDNA指导的 ⅱ 期结肠癌辅助化疗选择的有效性和成本-效果的早期评价

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-08-212
OAAI
Kramer, Astrid; Greuter, Marjolein J. E.; Schraa, Suzanna J.; Vink, Geraldine R.; Phallen, Jillian; Velculescu, Victor E.; Meijer, Gerrit A.; van den Broek, Daan; Koopman, Miriam; Roodhart, Jeanine M. L.; Fijneman, Remond J. A.; Retel, Valesca P.; Coupe, Veerle M. H.
Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer

根据III期结肠癌的共识分子亚型，辅助化疗对无复发生存期的益处

INTERNATIONAL JOURNAL OF CANCER
IF4.7
2024-08-083
OAAI
van de Weerd, Simone; Torang, Arezo; van den Berg, Inge; Lammers, Veerle; van den Bergh, Saskia; Brouwer, Nelleke; Nagtegaal, Iris D.; Koopman, Miriam; Vink, Geraldine R.; van der Baan, Frederieke H.; van Krieken, Han; Koster, Jan; Ijzermans, Jan N.; Roodhart, Jeanine M. L.; Medema, Jan Paul

研究方向

暂未获取到该数据
M
Miriam Koopman
H 指数:57论文数:448被引数:1.6万
J
Jeanine M.L. Roodhart
H 指数:28论文数:189被引数:3,642
G
Gerrit A. Meijer
H 指数:89论文数:1,107被引数:3.4万
C
Cornelis J.A. Punt
H 指数:97论文数:706被引数:5.1万
R
Remond J.A. Fijneman
H 指数:45论文数:319被引数:9,770
V
Veerle M.H. Coupé
H 指数:43论文数:365被引数:6,242
M
Marloes A.G. Elferink
H 指数:32论文数:153被引数:3,921
D
Daan van den Broek
H 指数:28论文数:160被引数:2,773
M
Marjolein J.E. Greuter
H 指数:19论文数:95被引数:1,122
S
Suzanna J. Schraa
H 指数:6论文数:23被引数:182